Page 2 - Balloon System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Let us talk about different ways in which technology has played a major role in improving the medicinal industry.

Novan Inc. (NASDAQ: NOVN) Obalon Therapeutics Inc. One of the biggest gainers during the second week of March is Obalon Therapeutics. On Tuesday, shares of OBLN skyrocketed. While no news came out on Tuesday to spark this gain, we saw several similar biotech penny stocks jump during the day. Obalon is a producer of medical devices that help treat obesity in the U.S. While it does have operations worldwide, its primary market is in America. Only a month or so ago, the company announced a merger with the weight loss solutions company, ReShape Lifesciences Inc. Upon the announcement, shares o...

Global Rectal Irrigation Market Industry Estimates and Insights, 2020 – 2027 A robust database of potential market estimations based on historical data analysis is included in the global market report. It helps consumers to provide quantified details for current market perusal. It is a comprehensive and technical study that focuses on primary and secondary drivers, market share, leading segments, and regional analysis. Key actors, major alliances, merger & acquisitions, and upcoming and trending innovation are pointed out. Company policies are checked, showing better outcomes from a techno-...

ReShape Lifesciences Inc. (OTCQB: RSLS) reported entry into a definitive agreement to merge with Obalon Therapeutics, Inc. (NASDAQ: OBLN). The company’s will merge in an all-stock transaction. The merger has been approved by boards of directors in each company as existing ReShape stockholders will receive majority ownership of the combined company following close of the... ReShape Lifesciences Inc. (OTCQB: RSLS) reported entry into a definitive agreement to merge with Obalon Therapeutics, Inc. (NASDAQ: OBLN).

ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering SAN CLEMENTE, CA / ACCESSWIRE / January 20, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a global weight-loss solutions leader, announced today that it has entered into a definitive merger agreement with Obalon Therapeutics, Inc., which is listed on the NASDAQ Capital Market, a company focused on developing and commercializing novel technologies for weight loss, under which ReShape and Obalon will combine in an all-stock transaction. Under the terms of the merger agreement that has been...